Gene · 3003
NIH grants2,103
NIH grants whose papers are about the gene, through NIH's grant-paper links.
1,101 to 1,120 of 2,103
Download this page as JSON| Grant | Title | GZMK papers | Newest fiscal year |
|---|---|---|---|
| U19AI111224 | Metabolic factors that control the spectrum of human tuberculosis | 6 | 2021 |
| T32GM007753 | Medical Scientist Training Program | 5 | 2021 |
| U54CA209975 | Systems biology of the tumor immune microenvironment | 4 | 2021 |
| K01AR072129 | Integrative Biology Approach to Identify and Characterize Roles of lncRNAs Associated with Psoriasis Pathology | 3 | 2021 |
| R01CA223484 | Determinants of prostate cancer sensitivity to PD-1 blockade | 3 | 2021 |
| R01HG009518 | Big Data Methods for Decoding Gene Regulation | 3 | 2021 |
| RC2DK114784 | Systematic dissection of gut cellular circuits [at single cell resolution] | 3 | 2021 |
| UM1AI126620 | First-in-human study of two anti-SARS CoV-2 antibodies in health volunteers | 3 | 2021 |
| P50CA097274 | Lymphoma Specialized Program of Research Excellence (SPORE) in Human Cancer | 2 | 2021 |
| R00AI135031 | Genetic and Biochemical Interrogation of Rotavirus-Cohesin Interaction | 2 | 2021 |
| R01AI127828 | Human neutralizing antibodies for Zika virus | 2 | 2021 |
| R01AI129191 | Memory T Cell Development and Survival in T Cell Responses of Older Individuals | 2 | 2021 |
| R01AI132389 | UPIT: Unleash the Potential of Intestinal Transplantation | 2 | 2021 |
| R01AI135270 | Structural and functional analysis of the coronavirus spike protein fusion peptide | 2 | 2021 |
| R01CA213062 | Molecular mechanisms of Nutrient sensing in cancer | 2 | 2021 |
| R01CA218526 | High-throughput palmitoyl-proteomics profiling of extracellular vesicles for identification of biomarkers for early detection of clinically significant prostate cancer | 2 | 2021 |
| R01DK117263 | Lysosome Homeostasis and Microbicidal Mechanisms in Innate Immunity | 2 | 2021 |
| R01GM131399 | Construction of cell specific gene co-regulations signatures based on single cell transcriptomics analysis | 2 | 2021 |
| U01CA217851 | Organoid-based Discovery of Oncogenic Drivers and Treatment Resistance Mechanisms | 2 | 2021 |
| U01CA217864 | Integrating targeted and immunotherapy to treat genetically heterogeneous cancers | 2 | 2021 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3003/grants?page=56